Jennifer Visser-Rogers, Statistician | Research & Publications

RESEARCH INTERESTS

My research is generally focussed on statistical methodology, with applications of statistics to health care. My main area of research to date has been on the development and application of novel statistical methods for the analysis of large-scale clinical trials. My principal theoretical interests are survival analysis and the analysis of recurrent events with a particular interest in joint modelling strategies that combine the two. My current major medical collaborations are in cardiovascular disease and previously in epilepsy. My PhD Thesis was titled "Statistical models for censored point processes with cure fractions" and you can read a copy here (should you so wish).

PUBLICATIONS

Academic Publications

K.G. Pollock, C. Dickerson, M. Kainth, S. Lawton, M. Hurst, D.M. Sugrue, C. Arden, D.W. Davies, AC. Martin, B. Sandler, J. Gordon, U. Farooqui, D. Clifton, C. Mallen, J. Rogers, N.R. Hill, A.J. Camm, A.T. Cohen. Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers. BMC Primary Care 2024; 25(7). DOI: 10.1186/s12875-023-02246-8

KL. Royle, D. Meads, J.K. Visser-Rogers, I.R. White, D.A. Cairns. How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review. Trials 2023; 24(708). DOI: 10.1186/s13063-023-07730-1

N.R. Hill, L. Groves, C. Dickerson, R. Boyce, S. Lawton, M. Hurst, K.G. Pollock, D.M. Sugrue, S. Lister, C. Arden, D.W. Davies, AC. Martin, B. Sandler, J. Gordon, U. Farooqui, D. Clifton, C. Mallen, J. Rogers, A.J. Camm, A.T. Cohen. Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England. Journal of Medical Economics 2022; 25(1):974-983. DOI: 10.1080/13696998.2022.2102355

N.R. Hill, C. Arden, L. Beresford-Hulme, A.J. Camm, D. Clifton, D.W. Davies, U. Farooqui, J. Gordon, L. Groves, M. Hurst, S. Lawton, S. Lister, C. Mallen, A.C. Martin, P. McEwan, K.G. Pollock, J. Rogers, B. Sandler, D.M. Sugrue, A.T. Cohen. Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial. Contemporary Clinical Trials 2020; 99:106191. DOI: 10.1016/j.cct.2020.106191

K.V. Bunting, R.P. Steeds, L.T. Slater, J.K. Rogers, G.V. Gkoutos, and D. Kotecha. A Practical Guide to Assess the Reproducibility of Echocardiographic Measurements. Journal of the American Society of Echocardiography 2019; 32(12): 1505-1515. DOI: 10.1016/j.echo.2019.08.015.

K.D. Lynch, R.W. Chapman, S. Keshav, A.J. Montano-Loza, A.L. Mason, A.E. Kremer, M. Vetter, M. Krijger, C.Y. Ponsioen, P. Trivedi, G. Hirschfield, C. Schramm, C. Heng Liu, C.L. Bowlus, D.J. Estes, D. Pratt, C. Hedin, A. Bergquist, A.C. Vries, C.J. Woude, L. Yu, D.N. Assis, J. Boyer, H. Ytting, E. Hallibasic, M. Trauner, H. Marschall, L.M. Daretti, M. Marzioni, K.K. Yimam, N. Perin, A. Floreani, B. Beretta-Piccoli, J.K. Rogers, International Primary Sclerosing Cholangitis Study Group (IPSCSG), and C. Levy. Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2019; DOI: 10.1016/j.cgh.2019.05.013.

P. Royston, B Choodari-Oskooei, M.K.B. Parmar, and J.K. Rogers. Combined test versus logrank/Cox test in 50 randomised trials. Trials 2019; 20(1): 172. DOI: 10.1186/s13063-019-3251-5.

B.R.H. Sturrock, J.K. Rogers, R. Sadler, B. Ferry, C.A. Roberts, R.W. Chapman and K.D. Williamson. Anti-gp210 and anti-sp100 antibody status and ursodeoxycholic acid response in primary biliary cholangitis. Journal of Gastroenterology and Hepatology Research 2018; 7(6): 2741-2747. DOI: 10.17554/j.issn.2224-3992.2018.07.797.

L. Shen, P.S. Jhund, U.M. Mogensen, L. Køber, B. Claggett, J.K. Rogers and J.J.V. McMurray. Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits. JACC: Heart Failure 2017; 5(8):591-599. DOI: 10.1016/j.jchf.2017.04.005.

J.K. Rogers, A.Yaroshinsk, S.J. Pocock, D. Stokar and J. Pogoda. Analysis of recurrent events with in the presence of informative censoring: Application of the joint frailty model. Statistics in Medicine 2016; 35(13):2195-2205. DOI: 10.1002/sim.6853.

J.K. Rogers, A. Kielhorn, J.S. Borer I. Ford and S.J. Pocock. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Current Medical Research & Opinion 2015; 31(10):1903-1909. DOI: 10.1185/03007995.2015.1080155.

J.K. Rogers, P.S. Jhund, A.C. Perez M. Böhm, J.G. Cleland, L. Gullestad, J. Kjekshus, D.J. Veldhuisen, J. Wikstrand, H. Wedel, J.J.V. McMurray and S.J. Pocock. Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations: The CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). Journal of the American College of Cardiology: Heart Failure 2014; 2(3):289-297. DOI: 10.1016/j.jchf.2013.12.007.

J.K. Rogers, S.J. Pocock, J.J.V. McMurray, C.B. Granger, E.L. Michelson, J. Östergren, M.A. Pfeffer, S.D. Solomon, K. Swedberg and S. Yusuf. Analysing recurrent hospitalisations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. European Journal of Heart Failure 2014; 16:33-40. DOI: 10.1002/ejhf.29.

J.K. Rogers and J.L. Hutton. Comparing treatment policies in early epilepsy through the joint modelling of pre-randomisation event rates and multiple post-randomisation survival times. Journal of Applied Statistics 2013; 40(3):546-562. DOI: 10.1080/02664763.2012.748720.

J.K. Rogers, J.J.V. McMurray, S.J. Pocock F. Zannad, H. Krum, D.J. Veldhuisen, K. Swedberg, H. Shi, J. Vincent and B. Pitt. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms: Analysis of the Repeat Hospitalizations. Circulation 2012; 126(19):2317-2323. DOI: 10.1161/CIRCULATIONAHA.112.110536.

J.K. Rogers, J.L. Hutton, A.G. Marson, and D.W. Chadwick. Assessing the risk of subsequent tonic-clonic seizures in patients with a history of minor seizures. Journal of Neurology Neurosurgery and Psychiatry 2012; 83:803-809. DOI: 10.1136/jnnp-2011-300917.

Other Published Output

J. Visser-Rogers. Addressing gender inequality is for life, not just International Women’s Day. BioSpectrum Asia (Available from: https://www.biospectrumasia.com/opinion/121/23896/addressing-gender-inequality-is-for-life-not-just-international-womens-day.html)

J. Visser-Rogers. Women in Science: Follow your passion and you'll get to where you're meant to be. Outsourcing Pharma (Available from: https://www.outsourcing-pharma.com/Article/2024/03/27/This-week-s-woman-in-science-stats-star-Jennifer-Visser-Rogers)

J. Visser-Rogers. Modern Healthcare Challenges Require Modern Solutions: Cross-Subsector Partnerships Improve Everybody's Outcomes. International Clinical Trials The Women in Pharma 2023 (Available from: https://www.calameo.com/read/0061133856334263fe7bb?page=56)

D. Ashby and J. Visser-Rogers. Data Monitoring and Complex Clinical Trials: Toward a Solution. Association of Clinical Research Professionals, Clinical Researcher (Available from: https://acrpnet.org/2023/12/data-monitoring-and-complex-clinical-trials-toward-a-solution/)

J. Visser-Rogers. Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor Partnerships. Applied Clinical Trials (Available from: https://www.appliedclinicaltrialsonline.com/view/creating-strategic-relationships-the-changing-face-of-contract-research-organizations-and-sponsor-partnerships)

G. Partington, L. Govan, P. O’Hara, E. Foreman, and J. Visser-Rogers. How Statistical and Data Analysis Can Support Research Innovations in Rare Disease. Phastar Blog (Available from: https://phastar.com/knowledge-centre/publications/how-statistical-and-data-analysis-can-support-research-innovations-in-rare-disease/)

J.K. Rogers. Recurrent clinical trial events: Analyzing methodologies with cardiology examples . Drug Discovery and Development (Available from: https://www.drugdiscoverytrends.com/recurrent-clinical-trial-events-analyzing-methodologies-with-cardiology-examples/)

J.K. Rogers. How to make COVID-19 clinical trial statistics meaningful to the public. Drug Discovery and Development. (Available from: https://www.drugdiscoverytrends.com/how-to-make-covid-19-clinical-trial-statistics-meaningful-to-the-public/)

J.K. Rogers. The Opportunities and Challenges of Basket Studies. Phastar Blog (Available from: https://phastar.com/knowledge-centre/blogs/the-opportunities-and-challenges-of-basket-studies/)

J.K. Rogers. Number Needed to Treat for Recurrent Events – Event- or Patient-Based? Statistics Views, Wiley (Available from: http://www.statisticsviews.com/details/feature/8092601/Number-Needed-to-Treat-for-Recurrent-Events--Event--or-Patient-Based.html).

J.K. Rogers. Recurrent events analysis, not so straightforward! Statistics Views, Wiley (Available from: http://www.statisticsviews.com/details/feature/5786631/Recurrent-events-analysis-not-so-straightforward.html).

J.K. Rogers, J.L. Hutton and K. Hemming. Joint modelling of event counts and survival times. Centre for Research in Statistical Methodology, University of Warwick (Available from: http://www2.warwick.ac.uk/fac/sci/statistics/crism/research/paper09-44).

PROFESSOR JENNIFER VISSER-ROGERS

STATISTICIAN

RESEARCH INTERESTS

PUBLICATIONS

Academic Publications

Other Published Output